Skip to main content
 

Infectious Disease Response

Since its inception in 1969, USAMRIID has supported disease outbreak investigations across the nation and around the globe. A brief timeline appears below. Support includes any or all of the following core capabilities:

  • Consultation with subject matter experts
  • Definitive diagnostic testing
  • Genome sequencing and analysis
  • Training of field laboratory personnel
  • Development and testing of vaccines, drugs, and diagnostics for potential emergency use

1969

  • Venezuelan equine encephalitis, South America

1977

  • Rift Valley fever, Egypt

1982

  • Lassa fever patients quarantined at USAMRIID
  • Chikungunya, Indonesia
  • Eastern equine encephalitis, Maryland, US

1985

  • Korean hemorrhagic fever (KHF) clinical trial
  • Junin virus vaccine trial
  • KHF in US Marines, Okinawa

1987

  • Ebola virus, Democratic Republic of Congo (DRC)
  • Lassa fever, West Africa
  • Rift Valley fever, Senegal River Basin

1988

  • Infant botulism, San Francisco, US

1989

  • Reston virus, Virginia, US

1993

  • Sin Nombre virus, Four Corners, US

1995

  • Ebola virus, Zaire
  • Rift valley Fever, Kenya
  • Ebola, Ivory Coast

1999

  • West Nile virus, New York, US

2001

  • Anthrax letters (FL, NY, DC), US

2002

  • Ebola, Ivory Coast

2003

  • SARS (multiple states), US

2006

  • Plague, Colorado, US
  • Tularemia, Thailand
  • Monkeypox, DRC
  • Lassa fever, West Africa

2013

  • MERS, Arabian Peninsula

2014

  • Ebola, West Africa

2016

  • Zika virus, South America

2019

  • Ebola virus, DRC

2020

  • COVID-19, worldwide

2021

  • Monkeypox, US

2022

  • Ebola Sudan virus, Uganda

2023

  • Marburg virus, Equatorial Guinea and Tanzania


Last Modified Date: 27-Jul-2023